The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa
by Morillon, Y. M. II., Smalley Rumfield, C., Pellom, S. T., Sabzevari, A., Roller, N. T., Horn, L. A., et al. (2020). Front. Oncol. 10:549. doi: 10.3389/fonc.2020.00549
Due to a production error, an author name was incorrectly written as “Y. Maurice II Morillon.” The correct name is “Y. Maurice Morillon II.” The publisher apologizes for this mistake. The original article has been updated.
Keywords: humanized mouse, NSG-β2m−/−, bintrafusp alfa, immunotherapy, TGF-β
Citation: Frontiers Production Office (2020) Erratum: The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa. Front. Oncol. 10:1548. doi: 10.3389/fonc.2020.01548
Received: 17 July 2020; Accepted: 20 July 2020;
Published: 24 July 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org